When was Generico Pharma founded?

Generico Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Where is Generico Pharma located?

Generico Pharma is headquartered in St. Louis, United States.

How many employees does Generico Pharma have?

As of Sep 30, 2026, the latest employee count at Generico Pharma is 7.

Is Generico Pharma a funded company?

Generico Pharma is a funded company, having raised a total of $5.69M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 21, 2013.

When was the latest funding round of Generico Pharma?

Generico Pharma's latest funding was a $***** Series A round on Aug 05, 2015, with participation from 3 investors. Its primary sector is Traditional Pharmaceuticals. Globally, the Traditional Pharmaceuticals sector has seen $1.29B in funding in 2026 to date.

Where does Generico Pharma rank among its competitors?

Generico Pharma ranks 592nd amongst 1245 active competitors, of which 43 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Generico Pharma?

Generico Pharma's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Generico Pharma - 2026 Company Profile, Funding & Competitors

Generico Pharma is a deadpooled company based in St. Louis (United States), founded in 2012. It operates as a Pharmaceutical company focused on generic medications, launching soon. Generico Pharma has raised $5.69M in funding from Kinsale Capital Partners. The company has 1245 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Pharmaceutical company focused on generic medications, launching soon. This organization is dedicated to providing access to affordable healthcare solutions through the development and distribution of generic pharmaceuticals. The company operates within the broader healthcare industry, aiming to offer cost-effective alternatives to brand-name drugs. While details are limited at this stage, the business model likely involves research, development, manufacturing, and distribution of pharmaceutical products. The company's future operations will likely involve partnerships with healthcare providers, pharmacies, and other stakeholders within the pharmaceutical supply chain. The company is committed to adhering to industry regulations and quality standards to ensure the safety and efficacy of its medications.

Key Metrics

Founded Year

2012

Location

St. Louis, United States

Stage

Deadpooled

Total Funding

$5.69M in 3 rounds

Latest Funding Round

Series A, Aug 05, 2015, $*****

Investors

Kinsale Capital Partners & 3 more

Ranked

592^nd among 1245 active competitors

Employee Count

7 as on Sep 30, 2026

Similar Companies

Teva Pharmaceuticals & 1462 more

View Generico Pharma's full profile

Generico Pharma has raised a total funding of $5.69M over 3 rounds. Its first funding round was on May 21, 2013. Its latest funding round was a Series A round on Aug 05, 2015 for $*****. 3 investors participated in its latest round. Generico Pharma has 4 institutional investors.

Here is the list of recent funding rounds of Generico Pharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 05, 2015	8878230	Series A	2586610	9106959	4577008	5204005
Jul 28, 2015	3007435	Series A	8113999	1613102	1299288	2340825
May 21, 2013	7949906	Seed	1818915	6584047	6561236	8359638

Access funding benchmarks and valuations. Sign up today!

View details of Generico Pharma's funding rounds and investors

Generico Pharma's employee count trend

Generico Pharma has 7 employees as of Sep 26. Here is Generico Pharma's employee count trend over the years:

Employee count trend for Generico Pharma

Uncover Generico Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Generico Pharma include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Generico Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	$6.64M	Cipher International, AbbVie & 5 others	71/100
5th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
6th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
7th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
8th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
9th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
10th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
592nd	Generico Pharma 2012, St. Louis (United States), Deadpooled	Pharmaceutical company focused on generic medications, launching soon	$5.69M	BioSTL, Missouri Technology & 2 others	31/100